NasdaqCM - Delayed Quote USD
Aldeyra Therapeutics, Inc. (ALDX)
At close: November 6 at 4:00 PM EST
Environment, Social and Governance (ESG) Risk Ratings
Total ESG Risk Score
29.3
ESG Risk Score for Peers
| Name | Total ESG Risk score | E | S | G |
|---|---|---|---|---|
| RCKT Rocket Pharmaceuticals, Inc. | 29 | -- | -- | -- |
| RNAC Cartesian Therapeutics, Inc. | 29 | -- | -- | -- |
| ALDX Aldeyra Therapeutics, Inc. | 29 | -- | -- | -- |
| SRRK Scholar Rock Holding Corporatio | 29 | -- | -- | -- |
| OMGA Omega Therapeutics, Inc. | 29 | -- | -- | -- |
Controversy Level Sustainalytics’ Controversies Research identifies companies involved in incidents and events that may negatively impact stakeholders, the environment or the company’s operations. Controversies are rated on a scale from one to five with five denoting the most serious controversies with the largest potential impact.
Sustainalytics’ Controversies Research identifies companies involved in incidents and events that may negatively impact stakeholders, the environment or the company’s operations. Controversies are rated on a scale from one to five with five denoting the most serious controversies with the largest potential impact.
ESG data provided by Sustainalytics, Inc. Last Updated on 10/2024
ALDX
Category Average
N/A None Controversy Level
None 4 Severe
-- ALDX
0.4 Category Average
Product Involvement Areas Flags a company’s involvement in products, services and business activities commonly used for screening purposes.
Flags a company’s involvement in products, services and business activities commonly used for screening purposes.
| Products and Activities | Significant Involvement |
|---|---|
| Alcoholic Beverages | No |
| Adult Entertainment | No |
| Gambling | No |
| Tobacco Products | No |
| Animal Testing | Yes |
| Fur and Specialty Leather | No |
| Controversial Weapons | No |
| Small Arms | No |
| Catholic Values | No |
| GMO | No |
| Military Contracting | No |
| Pesticides | No |
| Thermal Coal | No |
| Palm Oil | No |
Related Tickers
ARDX Ardelyx, Inc.
6.49
+13.46%
CTMX CytomX Therapeutics, Inc.
1.0000
+0.70%
ABUS Arbutus Biopharma Corporation
3.9200
-1.01%
ADVM Adverum Biotechnologies, Inc.
7.94
+2.85%
OCUL Ocular Therapeutix, Inc.
10.94
+3.50%
KALA KALA BIO, Inc.
7.05
+5.22%
PHAT Phathom Pharmaceuticals, Inc.
18.00
-2.01%
CAPR Capricor Therapeutics, Inc.
18.23
-1.19%
ABEO Abeona Therapeutics Inc.
6.28
+1.13%
VNDA Vanda Pharmaceuticals Inc.
4.8900
+2.09%